| Product Code: ETC13157827 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Onchocerciasis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Onchocerciasis Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Onchocerciasis Market Revenues & Volume, 2021 & 2031F |
3.3 North America Onchocerciasis Market - Industry Life Cycle |
3.4 North America Onchocerciasis Market - Porter's Five Forces |
3.5 North America Onchocerciasis Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Onchocerciasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 North America Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 North America Onchocerciasis Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.9 North America Onchocerciasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 North America Onchocerciasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 North America Onchocerciasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Onchocerciasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Onchocerciasis Market Trends |
6 North America Onchocerciasis Market, 2021 - 2031 |
6.1 North America Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Onchocerciasis Market, Revenues & Volume, By Physical Examination, 2021 - 2031 |
6.1.3 North America Onchocerciasis Market, Revenues & Volume, By Skin Biopsy, 2021 - 2031 |
6.1.4 North America Onchocerciasis Market, Revenues & Volume, By Mazzotti Test, 2021 - 2031 |
6.1.5 North America Onchocerciasis Market, Revenues & Volume, By Nodulectomy, 2021 - 2031 |
6.1.6 North America Onchocerciasis Market, Revenues & Volume, By PCR Test, 2021 - 2031 |
6.1.7 North America Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Onchocerciasis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.2.3 North America Onchocerciasis Market, Revenues & Volume, By Supportive Care, 2021 - 2031 |
6.2.4 North America Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Onchocerciasis Market, Revenues & Volume, By Ivermectin, 2021 - 2031 |
6.3.3 North America Onchocerciasis Market, Revenues & Volume, By Moxidectin, 2021 - 2031 |
6.3.4 North America Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Onchocerciasis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 North America Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Onchocerciasis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Onchocerciasis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5.4 North America Onchocerciasis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.5 North America Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Onchocerciasis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 North America Onchocerciasis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.6.4 North America Onchocerciasis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Onchocerciasis Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.2.1 United States (US) Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.2.2 Canada Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.2.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.3 North America Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
7.3.1 United States (US) Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.2 Canada Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.4.1 United States (US) Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.4.2 Canada Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.4.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.5 North America Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 United States (US) Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Canada Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.1 United States (US) Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.2 Canada Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.3 Rest of North America Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Onchocerciasis Market Key Performance Indicators |
9 North America Onchocerciasis Market - Export/Import By Countries Assessment |
10 North America Onchocerciasis Market - Opportunity Assessment |
10.1 North America Onchocerciasis Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Onchocerciasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
10.3 North America Onchocerciasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.4 North America Onchocerciasis Market Opportunity Assessment, By Drug, 2021 & 2031F |
10.5 North America Onchocerciasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 North America Onchocerciasis Market Opportunity Assessment, By End User, 2021 & 2031F |
10.7 North America Onchocerciasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Onchocerciasis Market - Competitive Landscape |
11.1 North America Onchocerciasis Market Revenue Share, By Companies, 2022 |
11.2 North America Onchocerciasis Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here